Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02478125 | Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer | terminated | Phase 1 | 3 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 18, 2019 | clinicaltrials |
| NCT01262664 | A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 4, 2019 |
| clinicaltrials |
| NCT00544076 | ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer | terminated | Phase 3 | 110 | City of Hope Medical CenterOTHER | 1 | Jan 2, 2019 | clinicaltrials |
| NCT00924807 | Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer | terminated | Phase 1 / Phase 2 | 4 | Beth Israel Medical CenterOTHER | 1 | Dec 11, 2018 | clinicaltrials |
| NCT00526591 | Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer | terminated | Phase 2 | 17 | Jorge A. Garcia, MDOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT01703065 | Cabozantinib in Men With Castration-Resistant Prostate Cancer | terminated | Phase 2 | 9 | University of WashingtonOTHER | 1 | Dec 4, 2018 | clinicaltrials |
| NCT02494713 | Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer | terminated | Phase 2 | 4 | The University of Texas Health Science Center, HoustonOTHER | 1 | Nov 27, 2018 | clinicaltrials |
| NCT00103376 | Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer | terminated | Phase 2 | 23 | Medical University of South CarolinaOTHER | 1 | Nov 5, 2018 | clinicaltrials |
| NCT00080782 | Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases | terminated | Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00851682 | Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma | terminated | N/A | 65 | Washington University School of MedicineOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT02450201 | MRI With C13 Pilot Study Prostate Cancer | terminated | Early Phase 1 | 5 | University of California, San FranciscoOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT01354951 | Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer | terminated | Phase 2 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 19, 2018 | clinicaltrials |
| NCT00670046 | Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer | terminated | Phase 2 | 15 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT01795365 | Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer | terminated | N/A | 60 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT00953576 | Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer(KHLAD) | terminated | Phase 1 / Phase 2 | 11 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT01618838 | Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer | terminated | N/A | 4 | Georgetown UniversityOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT00527124 | Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | terminated | Phase 2 | 57 | National Cancer Institute (NCI)NIH | 1 | Aug 9, 2018 | clinicaltrials |
| NCT01439542 | FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer(FASTR) | terminated | Phase 2 | 19 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT02694380 | Measuring the Effect of Radiation Therapy on Patient Activity Levels | terminated | — | 32 | University of PittsburghOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT02250313 | PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study(PASCUAL) | terminated | — | 600 | MDx HealthINDUSTRY | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03073473 | Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers | terminated | — | 40 | Cota Inc.INDUSTRY | 1 | Jul 20, 2018 | clinicaltrials |
| NCT01983709 | Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer(MSC) | terminated | Phase 1 | 7 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 16, 2018 | clinicaltrials |
| NCT00458549 | Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery | terminated | N/A | 232 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 13, 2018 | clinicaltrials |
| NCT01335204 | Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer | terminated | Phase 1 / Phase 2 | 4 | Medical University of South CarolinaOTHER | 1 | Jul 13, 2018 | clinicaltrials |
| NCT02491411 | Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel(DEXTER) | terminated | N/A | 5 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT00798837 | Intraprostatic MAXimal Simultaneous Boost | terminated | N/A | 10 | British Columbia Cancer AgencyOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT00634582 | Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases | terminated | Phase 2 | 2 | Wake Forest University Health SciencesOTHER | 1 | Jul 6, 2018 | clinicaltrials |
| NCT01724619 | Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT | terminated | Early Phase 1 | 7 | Wake Forest University Health SciencesOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT01644136 | Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer | terminated | N/A | 99 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 28, 2018 | clinicaltrials |
| NCT02215161 | Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer | terminated | Phase 2 | 14 | University of California, San FranciscoOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT01845792 | Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer | terminated | Phase 2 | 7 | University of Colorado, DenverOTHER | 1 | Jun 4, 2018 | clinicaltrials |
| NCT01987193 | Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01) | terminated | — | 3 | University of FloridaOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT01522443 | Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer(COMET-2) | terminated | Phase 3 | 119 | ExelixisINDUSTRY | 5 | May 23, 2018 | clinicaltrials |
| NCT02284971 | Pilot Study of SBRT and CDX-1127 in Prostate Cancer(Prostate-04) | terminated | Phase 1 | 2 | James Larner, MDOTHER | 1 | May 17, 2018 | clinicaltrials |
| NCT02441517 | A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment | terminated | Phase 4 | 4 | Astellas Pharma Global Development, Inc.INDUSTRY | 1 | Apr 19, 2018 | clinicaltrials |
| NCT00096304 | Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 1 | 36 | Medical University of South CarolinaOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT00860158 | Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer | terminated | Phase 2 | 1 | Noah Hahn, M.D.OTHER | 1 | Mar 14, 2018 | clinicaltrials |
| NCT01859338 | Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI | terminated | — | 26 | Virginia Commonwealth UniversityOTHER | 1 | Mar 7, 2018 | clinicaltrials |
| NCT02349139 | Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | terminated | Phase 1 | 27 | Asana BioSciencesINDUSTRY | 1 | Mar 7, 2018 | clinicaltrials |
| NCT00004261 | EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | terminated | Phase 1 | — | University Health Network, TorontoOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT00638378 | Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer | terminated | Phase 2 | 22 | Incyte CorporationINDUSTRY | 1 | Feb 12, 2018 | clinicaltrials |
| NCT00003516 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | terminated | Phase 2 | 16 | Burzynski Research InstituteOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00447616 | Prostatectomy Prospective Database | terminated | — | 896 | Kenneth Peters, MDOTHER | 1 | Dec 26, 2017 | clinicaltrials |
| NCT00918645 | Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis(UCDCC#217) | terminated | N/A | 13 | University of California, DavisOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT02131207 | MRI Before Biopsy in Diagnosing Patients With Prostate Cancer | terminated | — | 139 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 21, 2017 | clinicaltrials |
| NCT00003533 | Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 2 | 12 | Burzynski Research InstituteOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT00348816 | Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer | terminated | Phase 2 | 21 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT01200810 | Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer | terminated | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00524589 | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | terminated | Phase 2 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Nov 20, 2017 | clinicaltrials |
| NCT01748890 | A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy | terminated | N/A | 4 | Massachusetts General HospitalOTHER | 1 | Oct 20, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jan 18, 2019source: clinicaltrials